Postpartum Psychiatric Disorders

In Brief: Problem-Solving Education Intervention Reduces Risk of Postpartum Depression

While many women are at risk for postpartum depression, we continue to struggle in providing adequate support and care to women in this setting, especially socioeconomically disadvantaged women.   In a randomized clinical trial including [...]

By |2017-07-05T22:29:29-04:00June 20th, 2017|Postpartum Psychiatric Disorders|Comments Off on In Brief: Problem-Solving Education Intervention Reduces Risk of Postpartum Depression

Lamotrigine Reduces Risk for Postpartum Relapse in Women with Bipolar Disorder

Numerous studies have demonstrated that women with histories of bipolar disorder are at high risk for postpartum illness.  Because of this increased risk for relapse during the postpartum period, we typically recommend that women with [...]

By |2025-06-26T09:07:00-04:00May 30th, 2017|Postpartum Psychiatric Disorders|Comments Off on Lamotrigine Reduces Risk for Postpartum Relapse in Women with Bipolar Disorder

Pilot Study of Telephone-Delivered Interpersonal Therapy for Women with Postpartum Depression

It is clear that screening for perinatal depression substantially improves detection; however, screening alone does not appear to improve rates of treatment or outcomes.  What we find is that many, if not most, women with [...]

By |2017-05-24T09:40:10-04:00May 24th, 2017|Postpartum Psychiatric Disorders|Comments Off on Pilot Study of Telephone-Delivered Interpersonal Therapy for Women with Postpartum Depression

Brexanolone: Related to Allopregnanolone, Effective for the Treatment of Postpartum Depression

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression.  SAGE-547, now called brexanolone, is an allosteric modulator of GABAA receptors.  This drug was initially under [...]

By |2017-05-10T09:40:41-04:00May 10th, 2017|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Brexanolone: Related to Allopregnanolone, Effective for the Treatment of Postpartum Depression

Perinatal Depression in Fathers: Who is At Greatest Risk?

While perinatal depression is typically considered to be a woman’s illness, a number of studies have suggested that, although men do not experience any of the dramatic physiologic or hormonal changes that go along with [...]

By |2017-04-04T09:59:11-04:00April 4th, 2017|Postpartum Psychiatric Disorders, Prevalence & Risk Factors, Psychiatric Disorders During Pregnancy|Comments Off on Perinatal Depression in Fathers: Who is At Greatest Risk?

Do DHA Supplements Make Babies Smarter? Yes, No, Maybe…

DHA or docosahexaenoic acid is an omega-3 fatty acid which is essential for the growth and development of the brain in infants and is required for maintenance of normal brain function in adults. Based on [...]

By |2017-03-31T13:40:58-04:00March 31st, 2017|Alternative & Complementary, Child Outcomes, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on Do DHA Supplements Make Babies Smarter? Yes, No, Maybe…

Dietary Supplements to Prevent Postpartum Depression? Proceed with Caution

Over the last few days, there has been a lot of buzz regarding the use of a nutritional supplement to reduce risk of postpartum depression.  Quoting one of these articles:  "'Women who take the supplement [...]

By |2017-03-21T09:54:44-04:00March 21st, 2017|Alternative & Complementary, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Dietary Supplements to Prevent Postpartum Depression? Proceed with Caution
Go to Top